Bhavna Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 28-12-2024
- Paid Up Capital ₹ 1.50 M
as on 28-12-2024
- Company Age 41 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 Cr
as on 28-12-2024
- Revenue 17.40%
(FY 2023)
- Profit 80.58%
(FY 2023)
- Ebitda 48.54%
(FY 2023)
- Net Worth 34.79%
(FY 2023)
- Total Assets 13.17%
(FY 2023)
About Bhavna Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹7.00 Cr.
Aarti Parkar, Dilip Parkar, Amey Dilip, and One other member serve as directors at the Company.
- CIN/LLPIN
U99999MH1983PTC031193
- Company No.
031193
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Oct 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bhavna Laboratories Pvt Ltd offer?
Bhavna Laboratories Pvt Ltd offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Nervous System and Antipsychotic API, Brain & Nervous System Drugs, Antiepileptic Drugs, Antifungal Cream, Ointment & Powder, Ketoconazole Cream, Antihistamines, API (Active Pharmaceutical Ingredients), Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Bhavna Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Parkar  | Managing Director | 06-Oct-1994 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aarti Parkar | Director | 01-Dec-1996 | Current |
| Amey Dilip | Director | 01-Aug-2007 | Current |
| Kinjal Parkar | Director | 28-Mar-2012 | Current |
Financial Performance of Bhavna Laboratories.
Bhavna Laboratories Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 17.4% increase. The company also saw a substantial improvement in profitability, with a 80.58% increase in profit. The company's net worth Soared by an impressive increase of 34.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavna Laboratories?
Unlock access to Bhavna Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Emay Pharmaceuticals Private LimitedActive 1 year 6 monthsAmey Dilip and Kinjal Parkar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Aug 2024 | ₹4.00 Cr | Open |
Others Creation Date: 18 Jan 2024 | ₹2.50 Cr | Open |
Others Creation Date: 26 Aug 2022 | ₹1.50 M | Open |
How Many Employees Work at Bhavna Laboratories?
Bhavna Laboratories has a workforce of 17 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavna Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavna Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
